Global Pharmaceuticals & Biotech Top Growth Stocks

Beijing Luzhu Biotechnology

Market Cap: HK$2.5b

A biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$94.1b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.6b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Camurus

Market Cap: SEK 31.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Syndax Pharmaceuticals

Market Cap: US$1.6b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Oscotec

Market Cap: ₩1.6t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$3.7b

Engages in the development of drug engaged in the research, development and commercialization of pharmaceutical products.

Bonesupport Holding

Market Cap: SEK 13.7b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Kuros Biosciences

Market Cap: CHF 773.0m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

HansBiomed

Market Cap: ₩381.5b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

Ardelyx

Market Cap: US$1.4b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Cutia Therapeutics

Market Cap: HK$1.1b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Ocumension Therapeutics

Market Cap: HK$3.9b

Engages in the research, discovery, development, and commercialization of ophthalmic therapies in China.

Pharma Mar

Market Cap: €1.2b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Capricor Therapeutics

Market Cap: US$1.5b

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

ARS Pharmaceuticals

Market Cap: US$963.2m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$37.6b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Achieve Life Sciences

Market Cap: US$569.8m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Forum Markets

Market Cap: US$77.2m

A financial technology company, develops a blockchain-based platform focused on the acquisition, structuring, and tokenization of real-world assets worldwide.

BioStem Technologies

Market Cap: US$73.6m

Engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States.

MindMaze Therapeutics Holding

Market Cap: CHF 36.4m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

CG Oncology

Market Cap: US$5.3b

A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.

Arcutis Biotherapeutics

Market Cap: US$3.2b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Oxford Biomedica

Market Cap: UK£737.6m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Bora Pharmaceuticals

Market Cap: NT$52.5b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Genovis AB (publ.)

Market Cap: SEK 1.2b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

NewAmsterdam Pharma

Market Cap: US$3.5b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.

Belite Bio

Market Cap: US$5.4b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.

Devyser Diagnostics

Market Cap: SEK 1.5b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

SIGA Technologies

Market Cap: US$308.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Insmed

Market Cap: US$20.7b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Everest Medicines

Market Cap: HK$9.3b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Praxis Precision Medicines

Market Cap: US$7.2b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.

Rezolute

Market Cap: US$477.4m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Citius Pharmaceuticals

Market Cap: US$14.9m

A biopharmaceutical company, focuses on the development and commercialization of critical care products.

TriSalus Life Sciences

Market Cap: US$255.5m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.